SPiNCAR: A systematic model to evaluate and guide actions for tackling AMR

PLoS One. 2022 Mar 10;17(3):e0265010. doi: 10.1371/journal.pone.0265010. eCollection 2022.

Abstract

Background: Italy records very alarming levels antimicrobial resistance (AMR), so a National Action Plan on Antimicrobial resistance (PNCAR) was developed, adopting the AMR European Union's recommendations based on the results of the ECDC site visit of January 2017. For achieving PNCAR objectives, it is necessary to support and harmonize the implementation of recommendations in all the different healthcare levels (regional authorities and local trusts), so the SPiNCAR project was launched to create a tool for reaching this goal.

Methods: We developed a framework based on a scientific literature and national and international guidelines. Firstly, we identified the major intervention areas for tackling AMR, then, for each area, we built a set of standards, both for regional authorities than for local trusts. Every standard is composed by a set of essential and additional criteria, which refer to a minimum or supplemental performance level respectively. The contents were firstly discussed by the project's team during face-to-face kick-off meetings, then confirmed with Delphi methodology and finally validated through a pilot study.

Results: The final framework consists of seven different areas that reflect the PNCAR structure: Governance, Surveillance and Monitoring, Appropriate Use of antimicrobials, Healthcare-associated Infections (HAIs) control and prevention, Education and Training, Alliance among Stakeholders, Implementation. The total number of standards for the regional framework was 34 with 264 criteria and for the local version 36 criteria with 279 standards.

Conclusion: The ongoing use of this tool, developed on international evidences and recommendations that were tailored on the Italian specific context, allows monitoring the improvement achieved over time and plan the next steps.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anti-Infective Agents*
  • Cross Infection* / prevention & control
  • Delivery of Health Care
  • Humans
  • Italy
  • Pilot Projects

Substances

  • Anti-Infective Agents

Grants and funding

S.B. acted as scientific reference of funds received by the National Centre for Disease Prevention and Control (CCM network) of the Italian Ministry of Health assigned in 2018 and available from https://www.ccm-network.it/imgs/C_27_MAIN_progetto_580_0_file.pdf The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.